Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7950

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph showing percent maintained over months for Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 20 mg, 10 mg doses, and placebo. The 40 mg dose maintains close to 100% over 6 months, while lower doses and placebo decrease over time.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph showing percent maintained over a 6-month period for groups taking Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, 10 mg, and a placebo group. The y-axis represents percent maintained, and the x-axis represents months, indicating higher maintenance percentages for the 40 mg and 20 mg doses compared to the 10 mg dose and placebo.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A line graph depicting the percentage of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The y-axis shows percent symptom-free patients, and the x-axis shows diary days from 0 to 28. Both Esomeprazole groups show higher symptom-free percentages than placebo over time.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph comparing the percent of patients symptom-free over a 28-day diary period among three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The Y-axis represents the percentage of patients symptom-free, and the X-axis shows diary days from 0 to 28.*
FDA Label Image

Ink1 (Ink1)

Ink1 (Ink1)
Esomeprazole Magnesium 40 mg delayed-release capsules shown in a transparent amber plastic bottle with a white child-resistant cap. The label includes the product name, strength, dosage form, active ingredient, and the labeler, A-S Medication Solutions. The bottle contains multiple capsules in red and white colors.*
FDA Label Image

Ink2 (Ink2)

Ink2 (Ink2)
Packaging label for Esomeprazole Magnesium 40 mg delayed release capsules by A-S Medication Solutions. The label features a white and blue color scheme with the product name prominently displayed, including dosage strength. It also shows capsule count details in red text and the labeler's branding in the upper left corner.*
FDA Label Image

Label Image (Lbl500907950)

Label Image (Lbl500907950)
Esomeprazole Magnesium delayed-release capsules, 40 mg strength, in a 90-capsule package labeled by A-S Medication Solutions. The label includes storage instructions to keep between 68 to 77 degrees Fahrenheit and a QR code for dosage information. The product NDC is 50090-7950-1.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of esomeprazole magnesium, showing two esomeprazole molecules complexed with one magnesium ion and associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.